📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: InnovHeart

1.1 - Company Overview

InnovHeart Logo

InnovHeart

Headquarter: Italy
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of transcatheter mitral valve replacement systems to treat patients with mitral valve disease, including the Saturn TMVR System designed for trans-apical or trans-septal delivery. Offers a novel therapeutic system to replace incompetent mitral valves based on safe, effective, and easy-to-use transcatheter technology.

Products and services

  • Novel Transcatheter Therapeutic System: InnovHeart produces a novel transcatheter therapeutic system enabling replacement of incompetent Mitral Valves, delivering safe, effective, easy-to-use functionality for patients with mitral valve disease
  • Saturn TMVR System: InnovHeart architects the transcatheter Saturn TMVR system for trans-apical or trans-septal delivery, replacing incompetent Mitral Valves safely, effectively, and with easy-to-use procedural handling
  • Transcatheter Mitral Valve Replacement Systems: InnovHeart engineers transcatheter mitral valve replacement products to treat mitral valve disease, suitable to replace incompetent Mitral Valves using safe, effective, easy-to-use technology

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to InnovHeart

Acarix Logo

Acarix

HQ: Denmark Website
  • Description: Provider of point-of-care acoustic diagnostics for coronary artery disease. Its CADScor System uses highly sensitive acoustics and advanced computational processing to analyze coronary blood flow and calculate a patient-specific CAD-score, indicating the risk of significant coronary stenosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acarix company profile →
VNUS Logo

VNUS

HQ: United States Website
  • Description: Provider of products and minimally invasive treatments for venous diseases, including the patented Closure System for patients with symptoms associated with venous reflux; a world leader in the development and marketing of minimally invasive treatments for venous diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VNUS company profile →
Estech Logo

Estech

HQ: United States Website
  • Description: Provider of medical device manufacturing and distribution focused on least invasive cardiac surgery products; privately held and based in San Ramon, California, with worldwide distribution.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Estech company profile →
Artegraft Logo

Artegraft

HQ: United States Website
  • Description: Provider of biologic vascular grafts derived from bovine carotid arteries, processed and sold for implantation primarily in hemodialysis patients, offering surgeons a biological alternative to synthetic grafts.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Artegraft company profile →
Quantum Genomics Logo

Quantum Genomics

HQ: France Website
  • Description: Provider of effective, well-tolerated therapeutic treatments for cardiovascular diseases, focused on controlling high blood pressure and preventing related risks such as heart failure, addressing unmet medical needs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quantum Genomics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for InnovHeart

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to InnovHeart

2.2 - Growth funds investing in similar companies to InnovHeart

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for InnovHeart

4.2 - Public trading comparable groups for InnovHeart

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to InnovHeart

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About InnovHeart

What does InnovHeart do?

InnovHeart is a provider of transcatheter mitral valve replacement systems to treat patients with mitral valve disease, including the Saturn TMVR System designed for trans-apical or trans-septal delivery. Offers a novel therapeutic system to replace incompetent mitral valves based on safe, effective, and easy-to-use transcatheter technology.

Who are InnovHeart's competitors?

InnovHeart's competitors and similar companies include Acarix, VNUS, Estech, Artegraft, and Quantum Genomics.

Where is InnovHeart headquartered?

InnovHeart is headquartered in Italy.

How many employees does InnovHeart have?

InnovHeart has 1,000 employees 🔒.

When was InnovHeart founded?

InnovHeart was founded in 2010 🔒.

What sector and industry vertical is InnovHeart in?

InnovHeart is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for InnovHeart

Who are the top strategic acquirers in InnovHeart's sector and industry

Top strategic M&A buyers and acquirers in InnovHeart's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for InnovHeart?

Top strategic M&A buyers groups and sectors for InnovHeart include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in InnovHeart's sector and industry vertical

Which are the top PE firms investing in InnovHeart's sector and industry vertical?

Top PE firms investing in InnovHeart's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in InnovHeart's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in InnovHeart's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in InnovHeart's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to InnovHeart include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in InnovHeart's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for InnovHeart?

The key public trading comparables and valuation benchmarks for InnovHeart include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for InnovHeart for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for InnovHeart with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in InnovHeart's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for InnovHeart with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in InnovHeart's' sector and industry vertical?

Access recent funding rounds and capital raises in InnovHeart's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for InnovHeart